M Ventures

Significant appointments of industry and academic experts to support Phase II development of ASN51 in Alzheimer’s Disease

beeOLED announced the appointment of Gerd Günther as a member and chairman of its Advisory Board.

Transformative surfaceome discovery technology enables a comprehensive map of the cancer cell surface to identify a multitude of novel druggable targets. Pipeline programs in Small Cell Lung Cancer and Microsatellite-Stable Colorectal Cancer.

Calypso is a European biotech developing CALY-002, an anti-IL-15 monoclonal antibody, for autoimmune indications. The acquisition of Calypso gives Novartis full rights to the candidate, which has potential in dermatology, gastrointestinal and rheumatology indications.

Bauke Anninga, PhD, is an investment director on the M Ventures Biotechnology team. Before joining M Ventures in 2019, he spent two years in the healthcare investment banking group at Jefferies International.

Christian Patze, MBA, is an executive director on the M Ventures Technology team, covering electronics, frontier tech and sustainability. Before joining M Ventures in 2016, he worked in Merck KGaA’s Inhouse Consulting Global Graduate Program.

Christian Uhrich joined M Ventures in 2019 as head of strategy and is currently an investment director on the Biotechnology team. Previously, he was a senior consultant in Merck KGaA’s Inhouse Consulting practice.

Hakan Goker, PhD, is managing director of M Ventures and heads biotechnology investments in healthcare and life sciences. He joined M Ventures in 2013 and has invested in the sector for 20 years.

M Ventures maintains global presence with offices in The Netherlands, Germany, Israel and the US.

M Ventures is the strategic corporate venture capital fund of Merck KGaA, investing in biotechnology and technology, including healthcare drug development, life science tools, electronics, and frontier technology and sustainability.

The privacy notice applies to visitors and users of websites and apps of Merck KGaA and/or its affiliates.

Merck KGaA operates and maintains the website; the notice provides its address and contact details.